ASSOCIATION OF ARTERIAL STIFFNESS WITH MARKERS OF VASCULAR ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE-Reference-Cited by-同舟云学术

ASSOCIATION OF ARTERIAL STIFFNESS WITH MARKERS OF VASCULAR ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Published:2018-03-06 Issue:67 Volume:1 Page:31-36
ISSN:1998-5029
Container-title:Bulletin physiology and pathology of respiration
language:en
Short-container-title:

Author:

Кулик Екатерина¹,Kulik Ekaterina²,Павленко Валентина¹,Pavlenko Valentina²,Нарышкина Светлана¹,Naryshkina Svetlana²

Affiliation:

1. Амурская государственная медицинская академия

2. Amur State Medical Academy

Abstract

In order to analyze the relationship between the indices of arterial stiffness and the markers of vascular endothelial dysfunction and systemic inflammation, 69 patients with severe COPD and high-risk (GOLD 2013) during an exacerbation were examined. The stiffness of the vascular wall was determined with the help of an automatic sphygmograph and a sphygmomanometer "VaSera VS-1000". For the study, the carotid-femoral pulse wave velocity (PWV-aorta), right and left cardiovascular vascular index (R/L-CAVI) were chosen. Determination of the indices of systemic inflammation and vascular damage was carried out in the blood serum by the method of enzyme immunoassay. Analysis of the quantitative characteristics of arterial stiffness in patients with severe COPD and high risk revealed that in general in the group the studied indices were significantly higher than those of healthy individuals. The mean age of the vessels in the group of patients exceeded the biological age by 11.5% and amounted, on average, to 68.46-1.22 years. The in-group analysis revealed that concentrations of biomarkers of systemic inflammation and endothelial dysfunction were higher in COPD patients with R-CAVI values greater than 9, compared with less than 9 in the R-CAVI group. In a separate correlation analysis, it was found that the increase in the basic indices of arterial stiffness was associated both with the level of the indicators of systemic inflammation, and with the biomarkers of endothelial dysfunction. The obtained interrelations show that the formation of excessive vascular stiffness in patients with severe COPD of high risk is associated with the activation of inflammatory mediators and endothelial dysfunction, mostly with high levels of high-sensitivity C-reactive protein, fibrinogen, endothelin-1, homocysteine and TNF-α, and that’s why the determination of these parameters of AS is recommended, first of all, to these patients. The registration of events that manifest interdependent changes in the processes of vascular bed remodeling, systemic inflammation and endothelial dysfunction will allow early detection of patients with increased cardiovascular risk and timely intensification of therapy in this category of patients

Publisher

Far Eastern Scientific Center Of Physiology and Pathology of Respiration

Subject

General Medicine

Reference14 articles.

1. Васюк Ю.А., Иванова С.В., Школьник Е.Л., Котовская Ю.В., Милягин В.А., Олейников В.Э., Орлова Я.А., Сумин А.Н., Баранов А.А., Бойцов С.А., Галявич А.С., Кобалава Ж.Д., Кожевникова О.В., Конради А.О., Лопатин Ю.М., Мареев В.Ю., Новикова Д.С., Оганов Р.Г., Рогоза А.Н., Ротарь О.П., Сергацкая Н.В., Скибицкий В.В. Согласованное мнение российских экспертов по оценке артериальной жесткости в клинической практике // Кардиоваскулярная терапия и профилактика. 2016. №15(2). С.4−19. doi:10.15829/1728-8800-2016-2-4-19, Vasyuk Y.A., Ivanova S.V., Shkolnik E.L., Kotovskaya Y.V., Milyagin V.A., Oleynikov V.E., Orlova Y.A., Sumin A.N., Baranov A.A., Boytsov S.A., Galyavich A.S., Kobalava Z.D., Kozhevnikova O.V., Konradi A.O., Lopatin Y.M., Mareev V.Y., Novikova D.S., Oganov R.G., Rogoza A.N., Rotar O.P., Sergatskaya N.V., Skibitsky V.V. Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention 2016; 15(2):4−19 (in Russian). doi:10.15829/1728-8800-2016-2-4-19

2. Кулик Е.Г., Павленко В.И., Нарышкина С.В. Фактор Виллебранда и дисфункция сосудистого эндотелия у больных хронической обструктивной болезнью легких // Амурский медицинский журнал. 2017. №1. С.41−43., Kulik E.G., Pavlenko V.I., Naryshkina S.V. Von Willebrand factor and vascular endothelial dysfunction in patients with chronic obstructive pulmonary disease. Amurskiy meditsinskiy zhurnal 2017; 1:41−43 (in Russian).

3. Мамаева М.Г., Демко И.В., Салмина А.Б., Собко Е.А., Малиновская Н.А., Крапошина А.Ю., Гордеева Н.В., Соловьева И.А. Клинико-патогенетические особенности формирования эндотелиальной дисфункции и артериальной ригидности у больных хронической обструктивной болезнью легких // Клиническая медицина. 2016. Т.94. №2. С.113−120., Mamaeva M.G., Demko I.V., Salmina A.B., Sobko E.A., Malinovskaya N.A., Kraposhina A.Yu., Gordeeva N.V., Solov'eva I.A. Clinical and pathogenetic peculiarities of development of endothelial dysfunction and arterial rigidity in patients with chronic obstructive pulmonary disease. Klin. Med. (Mosk.) 2016; 94(2):113−120 (in Russian).

4. Павленко В.И. Взаимосвязь биомаркеров системного воспаления с показателями артериальной ригидности при хронической обструктивной болезни легких при сочетании с ишемической болезнью сердца // Медицинская иммунология. 2011. Т.13. №4-5. С.496., Pavlenko V.I. The interdependence of biomarkers of systemic inflammation with arterial rigidity in chronic obstructive pulmonary disease in combination with ischemic heart disease. Meditsinskaya immunologiya 2011; 13(4-5):496 (in Russian).

5. Павленко В.И., Нарышкина С.В. Оценка степени влияния кардиоваскулярных факторов на ригидность сосудистой стенки у больных с сочетанной кардиопульмональной патологией // Материалы XI международной научной конференции «Системный анализ в медицине» (САМ 2017) / под общ. ред. В.П.Колосова. Благовещенск, 2017. С.107., Pavlenko V.I., Naryshkina S.V. Assessment of the degree of influence of cardiovascular factors risk on stiffness of the vascular wall in patients with combined cardiopulmonary diseases. In: Proceedings of the XI International Scientific Conference "System Analysis in Medicine". Blagoveshchensk; 2017: 107−110(in Russian).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROSPECTIVE 12 MONTH FOLLOW-UP OF ELECTROCARDIOGRAPHIC CHANGES IN THE LEFT HEART OF COPD PATIENTS AFTER CORONAVIRUS INFECTION;"Medical & pharmaceutical journal "Pulse";2023-11-30

2. Endotheliopathy and systemic inflammation: reversibility of cause-and-effect relationship in the pathological functional system (review of literature);Regional blood circulation and microcirculation;2022-12-26

3. Arterial stiffness and albuminuria as markers of endothelial dysfunction in those with chronic obstructive pulmonary disease;Tuberculosis and Lung Diseases;2021-04-06

4. CHRONIC KIDNEY DISEASE AS A MANIFESTATION OF COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE;Bulletin physiology and pathology of respiration;2018-10-05